Concepedia
Statistics
Publications
21
Citations
633
H-Index
17
Active since
1982
Affiliations
Dana-Farber Cancer Institute(Current)
Brigham and Women's Hospital
Harvard University
Dana-Farber Brigham Cancer Center
Harvard Stem Cell Institute
Roman M. Shapiro is an author at Dana-Farber Cancer Institute specializing in medicine, immunology, and hematology.
Publications per year
1982–2025
Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer
Francisco Vera-Badillo, Roman M. Shapiro, Alberto Ocaña et al. · Annals of Oncology · 2013 · 116 citations · Full text
Medicine, Oncology, Breast Oncology +13
Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responses
Shaobo Yang, Michal Sheffer, Isabel E. Kaplan et al. · Nature Biotechnology · 2024 · 55 citations · Full text
Life Sciences, Cancer Biology, Immunology +13
Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active
Jacqueline S. Garcia, Haesook T. Kim, H. Moses Murdock et al. · Blood Advances · 2021 · 46 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +17
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML
Jacqueline S. Garcia, Haesook T. Kim, H. Moses Murdock et al. · Blood Advances · 2024 · 43 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
Katie Maurer, Haesook T. Kim, Thomas M. Kuczmarski et al. · Blood Advances · 2021 · 38 citations · Full text
Medicine, Hematology, Immunology +12
1–5 of 21